UK Markets closed

MRK Jan 2024 100.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
13.200.00 (0.00%)
As of 09:18AM EST. Market open.
Full screen
Previous close13.20
Open31.80
Bid16.15
Ask16.50
Strike100.00
Expiry date2024-01-19
Day's range13.20 - 13.20
Contract rangeN/A
Volume1
Open interest213
  • Reuters

    Drug companies face COVID cliff in 2023 as sales set to plummet

    Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely. Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022. Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.

  • Simply Wall St.

    Merck Full Year 2022 Earnings: EPS Misses Expectations

    Merck ( NYSE:MRK ) Full Year 2022 Results Key Financial Results Revenue: US$59.3b (up 22% from FY 2021). Net income...

  • Zacks

    AbbVie Q4 Preview: What's in Store?

    AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.